Literature DB >> 30379141

Prevalence of Staphylococcus aureus and Use of Antistaphylococcal Therapy in Children Hospitalized with Pneumonia.

Jennifer M Frush1, Yuwei Zhu2, Kathryn M Edwards3, Carlos G Grijalva4, Isaac P Thomsen3, Wesley H Self5, Seema Jain6, Evan J Anderson7, Krow Ampofo8, Andrew T Pavia8, Sandra R Arnold9, Jonathan A McCullers9, Derek J Williams10.   

Abstract

Within a cohort of >2,000 children hospitalized with community-acquired pneumonia, staphylococcal pneumonia was rare (1%) but associated with adverse in-hospital outcomes. Despite this low prevalence, use of antistaphylococcal antibiotics was common (24%). Efforts are needed to minimize overuse of antistaphylococcal antibiotics while also ensuring adequate treatment for pathogen-specific diseases.
© 2018 Society of Hospital Medicine.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30379141      PMCID： PMC6321763          DOI： 10.12788/jhm.3093

Source DB:  PubMed          Journal:  J Hosp Med        ISSN： 1553-5592            Impact factor:   2.960


  19 in total

Review 1.  Pneumonia caused by methicillin-resistant Staphylococcus aureus.

Authors:  Ethan Rubinstein; Marin H Kollef; Dilip Nathwani
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

Review 2.  Blood Culture in Evaluation of Pediatric Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.

Authors:  Pui-Ying Iroh Tam; Ethan Bernstein; Xiaoye Ma; Patricia Ferrieri
Journal:  Hosp Pediatr       Date:  2015-06

3.  Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema.

Authors:  Anne J Blaschke; Caroline Heyrend; Carrie L Byington; Ignacio Obando; Isabel Vazquez-Barba; Elizabeth H Doby; E Kent Korgenski; Xiaoming Sheng; Mark A Poritz; Judy A Daly; Edward O Mason; Andrew T Pavia; Krow Ampofo
Journal:  Pediatr Infect Dis J       Date:  2011-04       Impact factor: 2.129

4.  An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.

Authors:  Carrie L Byington; LaShonda Y Spencer; Timothy A Johnson; Andrew T Pavia; Daniel Allen; Edward O Mason; Sheldon Kaplan; Karen C Carroll; Judy A Daly; John C Christenson; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2002-01-03       Impact factor: 9.079

5.  Variability in processes of care and outcomes among children hospitalized with community-acquired pneumonia.

Authors:  Thomas V Brogan; Matthew Hall; Derek J Williams; Mark I Neuman; Carlos G Grijalva; Reid W D Farris; Samir S Shah
Journal:  Pediatr Infect Dis J       Date:  2012-10       Impact factor: 2.129

6.  Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus.

Authors:  Blanca E Gonzalez; Gerardo Martinez-Aguilar; Kristina G Hulten; Wendy A Hammerman; Jorge Coss-Bu; Anna Avalos-Mishaan; Edward O Mason; Sheldon L Kaplan
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

Review 7.  Biology and management of methicillin resistant Staphylococcus aureus in cystic fibrosis.

Authors:  Nour Akil; Marianne S Muhlebach
Journal:  Pediatr Pulmonol       Date:  2018-08-02

8.  Predicting Severe Pneumonia Outcomes in Children.

Authors:  Derek J Williams; Yuwei Zhu; Carlos G Grijalva; Wesley H Self; Frank E Harrell; Carrie Reed; Chris Stockmann; Sandra R Arnold; Krow K Ampofo; Evan J Anderson; Anna M Bramley; Richard G Wunderink; Jonathan A McCullers; Andrew T Pavia; Seema Jain; Kathryn M Edwards
Journal:  Pediatrics       Date:  2016-10       Impact factor: 7.124

Review 9.  Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.

Authors:  George Sakoulas; Robert C Moellering
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

10.  Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia.

Authors:  Chris Stockmann; Krow Ampofo; Jarrett Killpack; Derek J Williams; Kathryn M Edwards; Carlos G Grijalva; Sandra R Arnold; Jonathan A McCullers; Evan J Anderson; Richard G Wunderink; Wesley H Self; Anna Bramley; Seema Jain; Andrew T Pavia; Anne J Blaschke
Journal:  J Pediatric Infect Dis Soc       Date:  2018-02-19       Impact factor: 3.164
View more
  1 in total

1.  Outcome of Severe Bacterial Pneumonia in the Era of Pneumococcal Vaccination.

Authors:  Teresa Del Rosal; María Belén Caminoa; Alba González-Guerrero; Iker Falces-Romero; María Pilar Romero-Gómez; Fernando Baquero-Artigao; Talía Sainz; Ana Méndez-Echevarría; Luis Escosa-García; Francisco Javier Aracil; Cristina Calvo
Journal:  Front Pediatr       Date:  2020-12-15       Impact factor: 3.418
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.